Partners Capital Investment Group »

Urogen Pharma shares owned by Partners Capital Investment Group

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Partners Capital Investment Group from 13F filings

Historical chart of Partners Capital Investment Group investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Partners Capital Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Partners Capital Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $307k 15k 19.95
2025-06-30 $211k 15k 13.70
2025-03-31 $170k 15k 11.06
2024-09-30 $195k 15k 12.70
2024-06-30 $258k 15k 16.78
2023-12-31 $231k 15k 15.00
2023-09-30 $216k 15k 14.01
2023-06-30 $159k 15k 10.35

More positions owned by Partners Capital Investment Group

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
Vanguard Short-Term Treasury ETF Short Term Treas (VGSH)
iShares Core MSCI Emerging Markets ETF Core Msci Emkt (IEMG)
iShares Currency Hedged MSCI EAFE ETF Hdg Msci Eafe (HEFA)
Vanguard S&P 500 ETF S&p 500 Etf Shs (VOO)
Vanguard Value ETF Value Etf (VTV)
iShares 0-5 Year TIPS Bond ETF 0-5 Yr Tips Etf (STIP)
Vanguard Total World Stock ETF Tt Wrld St Etf (VT)
iShares Core S&P Total US Stock Market ETF Core S&p Ttl Stk (ITOT)
iShares MSCI Emerging Markets ex China ETF Etf - Equity (EMXC)
iShares TIPS Bond ETF Tips Bd Etf (TIP)
iShares Core MSCI EAFE ETF Core Msci Eafe (IEFA)
Xtrackers MSCI Japan Hedged Equity ETF Xtrack Msci Japn (DBJP)
iShares MSCI ACWI ETF Msci Acwi Etf (ACWI)
iShares 7-10 Year Treasury Bond ETF 7-10 Yr Trsy Bd (IEF)

View all positions for Partners Capital Investment Group

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma